It’s been a decade since Sandoz Inc. launched Zarxio, referencing Amgen Inc.’s Neupogen (filgrastim), as the first biosimilar in the U.S. Zarxio was expected to be the beginning of a biosimilar boom ...

Kilmeade made the comment Sept. 10, 2025, and it spread widely online on Sept. 13. Kilmeade apologized Sept. 14, calling his remark "extremely callous." In the context of the segment in which it was ...

The rising cost of cancer care has appropriately received considerable attention in recent years. Irrespective of who the payer is, the increasing cost of cancer treatment ultimately trickles down to ...

Using semaglutide injections, scientists were able to reverse life-threatening cases of liver disease in a new clinical trial published in The New England Journal of Medicine. Semaglutide, which is ...

Samuel Whittle is supported by an Australia and New Zealand Musculoskeletal (ANZMUSC) Clinical Trial Network Practitioner Fellowship and by a grant from The Hospital Research Foundation Group. Dr ...

If you're thinking of getting an injection for back pain, you might want to think again. A panel of experts has examined the practice, found serious issues with its use – including financial gain – ...

Epidural steroid injections (ESIs) offer limited effectiveness in reducing back pain and disability, an updated review by the American Academy of Neurology (AAN) suggested. “They may modestly reduce ...

Bryan Johnson says using donor fat to increase volume in his face for a youthful look caused a “severe allergic reaction” Cara Lynn Shultz is a writer-reporter at PEOPLE. Her work has previously ...

Treatments for Dupuytren’s contracture include limited fasciectomy and collagenase injection. Comparisons of the effectiveness of these treatments have been limited. We performed an unblinded, ...

Association of Community-Level Social Vulnerability With Clinical Trial Discussion and Participation Among Cancer Survivors This was an observational, noninferiority, cohort study of patients from ...

Competition in the race to crack the lucrative weight loss drug market is heating up as rivals like Roche, Eli Lilly, Novo Nordisk and Pfizer develop oral medications that help people shed weight ...